MENU
FEB 2 - 3 2021
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

Leica Biosystems Multiplex User Meeting

YOU ARE INVITED!
Leica Biosystems and LabRoots
Multiplex User Meeting
Save your spot today!

February 2
Europe - 9:00 AM Central European Time
Americas - 3:00 AM East Coast  

February 3 
Asia-Pacific - 9:00 AM Singapore Standard Time 

Here is your opportunity to be part of the discussion and explore the new research capabilities on the Leica Biosystems BOND RX Fully Automated Research Stainer. 

In recent years, there are many developments to increase the capabilities of tissue immunohistochemistry. Multiplexing technology is one of the fastest growing areas in tissue research. Multiplexing allows detection and direct observation of different cell populations within a specimen (visualizing multiple markers at the same time on the same tissue).

Multiplexing offers a researcher these added values:
-    Disease panel development 
-    Maximizing information derived from precious samples
-    Acquiring in-depth information about marker interaction and co-localization
-    Receiving insights in cell populations and the tumor micro-environment

Our expert team at Leica Biosystems will share with you the latest developments of these applications.

Register now!  Participants will be able to:

•    Learn directly from Leica Biosystems’ product and application experts about our multiplexing solutions.
•    Explore the virtual exhibition space
•    Connect with peers in the networking lounge

We look forward to meeting with you at this exciting event!

RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES


Speakers

Show Resources
Agenda
Speakers

  • Damian Cockfield
    Global Product Manager - BOND, Leica Biosystems
    Biography
      Damian is the Global Product Manager for the clinical and research BOND systems and is based in Melbourne, Australia. Damian joined Leica Biosystems as a Scientist in 2007 working on the development of BOND-III. Throughout his career at Leica Biosystems he has held numerous roles working across the broad portfolio of Leica Biosystems products, included spending 7 years based out of the Newcastle UK site before returning to Australia in 2018.
    • Alexander David Borowsky, MD
      Professor, Pathology and Laboratory Medicine, Center for Immunology and Infectious Disease and UC Davis Comprehensive Cancer Center
      Biography
        Dr. Borowsky is a surgical and molecular pathologist with expertise in cancer diagnostics and model systems for cancer research. His research is primarily focused on human breast cancer and mouse models for this disease with extensive experience and accomplishments on many aspects of experimental pathology and animal models of human disease. He is a translational scientist with expertise in assay development and interpretation in the clinical setting, including experience with radiologic-pathologic image registration and comparative analysis, immunohistochemistry, FISH, and tissue and fixative preparation for conventional and innovative molecular analysis. His lab has pioneered techniques for mammary gland transplantation experiments, and has generated transgenic cancer models. Specific areas of interest in the laboratory include the tumor immune microenvironment, pre-cancer progression and cancer stem cell origins, cancer promoting microenvironments, and regulation of progression and reversion. The lab has a long track record of experimental pathology including interpretation of phenotypes, developmental and cancer, and interpretation of novel immunohistochemical studies, functional imaging technology, image analysis, and data informatics. Additional research interests extend to the development of novel in vivo imaging modalities, and use of these in preclinical and clinical trials. He directs clinical trials at UC Davis, including the completed Leica Genensis study for validation of digital whole slide imaging for pathology diagnosis, and ongoing WISDOM breast cancer screening, and the All of US NIH Precision medicine cohort studies; and leads the Pathology working group in the NCI MCL consortium and the PreCancer Atlas pilot project.
      • Helen Snyder, PhD
        Director of Preclinical Development & Strategic Partnerships Cell IDx
        Biography
          Received her PhD in immunology from the University of Cambridge, UK and trained as a postdoctoral fellow at Scripps Research Institute, La Jolla, California. Dr. Snyder has over 30 years' experience in immunology research, reagent development, preclinical development of biotherapeutics, and business development of immunoassay and immunodiagnostic products. She has held positions as Associate Professor at the University of California, San Diego, as well as Director of Immunology at Dynavax Technologies and key business development roles at both Solulink Biosciences and Cell IDx. Dr Snyder has over 40 papers and reviews in the areas of immune regulation and vaccine development and holds two patents.
        • Dean Talia, PhD
          Senior Scientist, Leica Biosystems
          Biography

            Dean joined Leica Biosystems in 2016 and is a senior scientist in the R&D team in Melbourne, working on advanced staining projects. He graduated from Monash University where he pursued a PhD, with the department of Immunology and Pathology. During this time, he investigated the role of T cell lineages in mediating inflammatory retinal disorders. He assessed cellular interactions using fluorescent multiplex IHC with confocal microscopy imaging of retinal wholemounts.

          • Jan von der Thüsen
            Lead Thoracic Pathologist Erasmus Medical Centre
            Biography

              Dr. Jan von der Thüsen is a histopathologist with subspecialist interests in thoracic and cardiovascular pathology. Thüsen received his medical training at the Universities of Cambridge (UK, Trinity College) and London (UK, Imperial College), and his specialist training at Leiden University Medical Centre (The Netherlands). His Ph.D. was also awarded by Leiden University for research into gene therapeutic approaches to atherosclerosis. He developed his subspecialist interest in thoracic pathology during appointments as consultant histopathologist and university lecturer at the Academic Medical Centre in Amsterdam (The Netherlands), and the Royal Brompton & Harefield NHS Foundation Trust in London. Thüsen currently works as the lead thoracic pathologist at the Erasmus Medical Centre in Rotterdam (The Netherlands), where his research interests include the pathology of neoplastic diseases of the lung and mediastinum, fibrotic lung disease, as well as the pathology of pulmonary and cardiac transplantation.

            Help

            General LabRoots Questions

            email support@labroots.com  

            Virtual Events and Webinars

            Supported Configurations

            • Operating System Internet Explorer Firefox Chrome Safari
              Vista IE8+ FF10+ Chrome15+
              Windows 7 IE8+ FF10+ Chrome15+
              Windows 8 IE10 FF10+ Chrome15+
              Mac OS X   FF10+ Chrome15+ Safari5.1+
            • Cookie settings: session cookies enabled
            • Browser configuration must have JavaScript enabled
            • Adobe Flash player 10.2 or later

            To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

            Internet Connection

            • A minimum of 100Kbps is recommended for audio-only events
            • A minimum of 300Kbps is recommended for speaker on-video events

            Computer Equipment

            • Screen Resolution: Minimum 1024x768
            • Video Card: 65,000 colors minimum
            • Sound card and speakers (or headphones) for hearing webcast in full format
            • Audio Card: 16-bit minimum
            • RAM: 512MB of free RAM

            Firewall Protocol

            • HTTP on port 80 or HTTPS on port 443
            • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
            • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

            Work-At-Home Attendees

            • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

            For A Seamless Experience

            When using a mobile device, FREE Mobile Apps are available:

            - For viewing Webinars:

            - For viewing Virtual Events

            Attendee Guide

            • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

            Virtual Event and Webinar Support:

            Continuing Education (CME/CE) Support

            Show Resources
            Event Countdown
            • 0 Days
            • 0 Hours
            • 0 Minutes
            • 0 Seconds
            Attendees
            • See more